A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)

A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)

Abstract Background Bone metastases represent an important source of morbidity in cancer patients, mostly due to severe pain. Radiotherapy is an established symptomatic treatment for painful bone metastases, however, when conventional techniques are used, the effectiveness is moderate. Stereotactic...

Full description

Bibliographic Details
Main Authors: Carole Mercier, Piet Dirix, Piet Ost, Charlotte Billiet, Ines Joye, Peter Vermeulen, Yolande Lievens, Dirk Verellen
Format: Article
Language:English
Published: BMC 2019-09-01
Series:BMC Cancer
Subjects:
Stereotactic body radiotherapy
Bone metastases
Spinal metastases
Pain
Online Access:http://link.springer.com/article/10.1186/s12885-019-6097-z

Internet

http://link.springer.com/article/10.1186/s12885-019-6097-z

Similar Items